Events

Loading Events

All Events

  • This event has passed.

Accelerate AI Project Ideation Plenary – Governance & Business Workstream

July 8 @ 1:00 pm - 3:00 pm

Register

 

The Accelerate AI | Collaborative Strategies project will address common obstacles to AI implementation. Participants will co-create a framework of best practices and strategies for addressing challenges in AI projects including data sharing, legal & compliance requirements, coordinating resources, skills, and domain expertise, obtaining leadership buy-in, and investment.

As part of the Accelerate AI project, we’ll be offering several plenary sessions to discuss how organizations can prepare themselves to deliver AI solutions, from the perspective of facilitating collaboration across teams (both internally and between organizations).

Ideation Plenary 
Surface ideas to address collaboration challenges and barriers that impede deployment of AI.

  • 3 PM – 5 PM, Tuesday, July 6, 2021: Legal & Compliance Workstream Plenary
  • 3 PM – 5 PM, Wednesday, July 7, 2021: Technology & Operations Workstream Plenary
  • 1 PM – 3 PM, Thursday, July 8, 2021: Governance & Business Workstream Plenary

Workstream Objectives

Governance & Business: Identify principles and perspectives on how to deliver value from AI initiatives and expedite collaboration across business units and organizations.

July 8th Agenda:

1:00 pm Welcome
1:10 pm Data Governance Collaboration with Open Data Initiative and Roche

Jennifer Pougnet, Data Policy Strategy Leader, Personalised Healthcare, Roche

Elea Himmelsbach, Senior Consultant, Open Data Initiative

1:25 pm Governance Tools for Biomedical Data Commons

Incoming Doctoral Candidate, Faculty of Law, University of Toronto

Academic Associate, Centre of Genomics and Policy, McGill University

1:45 pm Five Key Lessons: AI Collaborations with Accounting and Law Firms

Benjamin Alarie, Professor & Osler Chair in Business Law, Faculty of Law, University of Toronto

Faculty Affiliate, Vector Institute

2:05 pm Product Certification for AI Systems

Noam Kolt, Inaugural Graduate Fellow, Schwartz Reisman Institute for Technology and Society

Doctoral Candidate, Faculty of Law, University of Toronto

2:25 pm Approaching Governance, Systems and Processes During Agile Transformation @ Roche – Successes and Lessons Learned

Loredana Regep, VP Medical and Regulatory Affairs, Roche Canada

2:40 pm Panel Q&A and Open Discussion

 

Speakers:

Jennifer Pougnet
Data Policy Strategy Leader, Personalised Healthcare, Roche

Jennifer has served in large-scale public health systems in Canada implementing Electronic Medical Records as well as developing and implementing both operational and legislative health policy. She has worked with Roche on innovative funding pathways for companion diagnostics and Next Generation Sequencing and now serves as the Global Data Policy Strategy Lead for Personalised Healthcare in Switzerland. She has a Masters of Business Administration, a Masters of Public Health with a specialization in Policy and recently earned her certificate in Data: Law, Policy & Regulation from the London School of Economics. She serves on the EFPIA Digital Health Working Group, Digital Europe Digital Health and AI & Data Working Groups as well as the BIO Digital Trade Task Force focusing on progressing data and digital policy globally.

 

 

 

 

 

Elea Himmelsbach
Senior Consultant, Open Data Initiative (ODI)

Elea is a member of the delivery team at the Open Data Initiative, working for the R&D programme and clients such as Microsoft. She leads a stimulus fund programme, and works on topics such as building trust, peer learning, data infrastructure and data access.

 

Prior to joining the ODI, Elea worked in the arts and culture sector as a curator, archivist and lecturer. She has played a pivotal role in shaping digital archive collections such as The Photographers’ Gallery, Science Ltd, and the Contemporary Art Society.

 

Her interest in open data originates from her practical experiences in developing frameworks for digital collections. She has developed tools and guidance to increase access to and ensure the long-term preservation of collection data.

 

 

Alexander Bernier
Incoming Doctoral Candidate, Faculty of Law, University of Toronto
Academic Associate, Centre of Genomics and Policy, McGill University

Alexander Bernier is a Canadian lawyer, and incoming doctoral student at the University of Toronto Faculty of Law. He is an Academic Associate at the Centre of Genomics and Policy at McGill University. In this capacity, he develops ethical and legal governance frameworks for international biomedical research consortia, including the European-Canadian Cancer Network, Canada’s national COVID-19 Immunity Task Force, and euCanSHare, a population health project that brings together longitudinal cohort studies in Canada and the European Union. Alexander is a member of the International Cancer Genome Consortium Data Access Committee. He also coordinates the Ethics Working Group of the Human Cell Atlas, an interdisciplinary group that develops ethics and data governance tools for HCA researchers. His research interests include the collective stewardship of biomedical data, the regulation of emerging technologies, and the intersection of open science and data protection.  

 

 

 

 

Benjamin Alarie
Professor & Osler Chair in Business Law, Faculty of Law, University of Toronto
Faculty Affiliate, Vector Institute

Benjamin Alarie, M.A. (Toronto), J.D. (Toronto), LL.M. (Yale) researches and teaches in taxation law and judicial decision-making. Before joining the Faculty of Law, Professor Alarie was a graduate fellow at Yale Law School (2002-2003) and a law clerk for Madam Justice Louise Arbour at the Supreme Court of Canada (2003-2004). Over the years his publications have appeared in numerous academic journals, including the British Tax Review, the Canadian Tax Journal, and the American Business Law Journal. His research has been funded by the Social Sciences and Humanities Research Council, the Canadian Foundation for Innovation, and the Ontario Ministry of Research and Innovation. He is coauthor of several editions of Canadian Income Tax Law (LexisNexis) and was awarded the Alan Mewett QC Prize for Excellence by the JD class of 2009. Beyond his academic career, Professor Alarie is co-founder and CEO of Blue J Legal and an affiliated faculty member of the Vector Institute for Artificial Intelligence.

 

Noam Kolt
Inaugural Graduate Fellow, Schwartz Reisman Institute for Technology and Society
Doctoral Candidate, Faculty of Law, University of Toronto

Noam Kolt is a doctoral candidate at the University of Toronto Faculty of Law. His research focuses on contract law, computational text analysis, and the governance of artificial intelligence. Noam was appointed an inaugural Schwartz Reisman Institute for Technology and Society Graduate Fellow and held an Ethics of AI Graduate Research Fellowship at the University of Toronto Centre for Ethics. Noam’s scholarship has been published or is forthcoming in the Berkeley Technology Law Journal, Yale Law & Policy Review, International Journal of Constitutional Law, and Melbourne University Law Review.

 

 

 

 

 

 

 

Loredana Regep
VP Medical and Regulatory Affairs, Roche Canada

Loredana Regep, M.D. works as VP Medical and Regulatory Affairs for Roche Canada since January 2019. Before joining Roche Canada, over the last 6 years she held the positions of Country Medical Director for Roche Czech Republic and Roche Norway respectively.

 

Before joining the Norwegian affiliate, Loredana worked as International Medical Leader at Roche Basel (Global Medical Affairs), focusing on Virology for the first 2 years and later on taking on additional responsibilities for a number of Established Products.

 

Loredana studied medicine at Ovidius University of Constanta, Romania and obtained her medical degree at Carol Davila University, Bucharest. After having worked as a physician at the County Hospital, Loredana started early on her career in the pharmaceutical industry at Eli Lilly (1999) and moved to Roche in March 2002. Here, Loredana held various positions of increasing responsibility in Virology, starting in Commercial and in 2006, moving to the Medical department, where she was in charge of both medical activities and clinical trials. She holds a Certificate of Advanced Studies in Pharmaceutical Medicine from the University of Basel (2015).

 

Loredana is passionate about people, innovation and leadership and has a broad pharma industry perspective. In her recent career as medical affairs leader, Loredana was able to build in a short time strong medical affairs teams and create impactful disease area strategies, both in global and affiliate.  More recently, she has been involved in leading or facilitating innovation strategies, organizational transformation and co-leading a global pan-neurology working group aiming to identify innovative approaches to catalyze transformation of medical practice in the field.

 

Scroll to Top